News LivaNova PLC

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
60.04 ^USD	+0.74%		-0.83%	+16.04%

May. 01	LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance	MT
May. 01	Transcript : LivaNova PLC, Q1 2024 Earnings Call, May 01, 2024

LivaNova to Present at the Goldman Sachs Healthcare Conference	May. 23	BU
LivaNova : 1Q 2024 Earnings Press Release	May. 02	PU
LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance	May. 01	MT
Transcript : LivaNova PLC, Q1 2024 Earnings Call, May 01, 2024	May. 01
Earnings Flash (LIVN) LIVANOVA Reports Q1 Revenue $294.9M, vs. Street Est of $278.2M	May. 01	MT
Earnings Flash (LIVN) LIVANOVA Posts Q1 EPS $0.73, vs. Street Est of $0.49	May. 01	MT
LivaNova: Q1 Earnings Snapshot	May. 01	AQ
LivaNova Reports First-Quarter 2024 Results	May. 01	BU
LivaNova PLC Provides Earnings Guidance for the Full-Year 2024	May. 01	CI
LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	Apr. 30	BU
LivaNova PLC Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	Apr. 30	CI
LivaNova : 2023 UK Annual Report	Apr. 26	PU
LivaNova : 2024 Proxy Statement and Notice of Annual General Meeting	Apr. 26	PU
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident	Apr. 25	BU
LivaNova to Announce First-Quarter 2024 Results	Mar. 21	BU
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 20	MT
Sector Update: Health Care Stocks Down Wednesday Afternoon	Mar. 20	MT
LivaNova Says Sleep Apnea Study Likely to Meet Primary Efficacy Endpoint; Shares Jump	Mar. 20	MT
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	Mar. 20	BU

No results for this search